Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.

Dimitriou F, Orloff MM, Koch Hein EC, Cheng PF, Hughes IF, Simeone E, Montazeri K, Grover P, Mehmi I, Gerard CL, Gaudy-Marqueste C, Grob JJ, Michielin O, Hamid O, Long GV, Sullivan R, Kapiteijn E, Johnson DB, Ascierto PA, Joshua AM, Carvajal RD, Butler MO, Hassel JC, Dummer R

Open source

DOI: 10.1016/j.ejca.2024.115161
Published: 2025 Jan
Container: European journal of cancer (Oxford, England : 1990)
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2024.115161,
  title = {Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.},
  author = {Dimitriou F and Orloff MM and Koch Hein EC and Cheng PF and Hughes IF and Simeone E and Montazeri K and Grover P and Mehmi I and Gerard CL and Gaudy-Marqueste C and Grob JJ and Michielin O and Hamid O and Long GV and Sullivan R and Kapiteijn E and Johnson DB and Ascierto PA and Joshua AM and Carvajal RD and Butler MO and Hassel JC and Dummer R},
  year = {2025},
  journal = {European journal of cancer (Oxford, England : 1990)},
  doi = {10.1016/j.ejca.2024.115161},
  url = {https://doi.org/10.1016/j.ejca.2024.115161}
}

RIS

TY  - JOUR
TI  - Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.
AU  - Dimitriou F
AU  - Orloff MM
AU  - Koch Hein EC
AU  - Cheng PF
AU  - Hughes IF
AU  - Simeone E
AU  - Montazeri K
AU  - Grover P
AU  - Mehmi I
AU  - Gerard CL
AU  - Gaudy-Marqueste C
AU  - Grob JJ
AU  - Michielin O
AU  - Hamid O
AU  - Long GV
AU  - Sullivan R
AU  - Kapiteijn E
AU  - Johnson DB
AU  - Ascierto PA
AU  - Joshua AM
AU  - Carvajal RD
AU  - Butler MO
AU  - Hassel JC
AU  - Dummer R
PY  - 2025
JO  - European journal of cancer (Oxford, England : 1990)
DO  - 10.1016/j.ejca.2024.115161
UR  - https://doi.org/10.1016/j.ejca.2024.115161
ER  -

APA

F, D., MM, O., EC, K. H., PF, C., IF, H., E, S., K, M., P, G., I, M., CL, G., C, G., JJ, G., O, M., O, H., GV, L., R, S., E, K., DB, J., PA, A., AM, J., RD, C., MO, B., JC, H., & R, D. (2025). Treatment sequence with tebentafusp and immune checkpoint inhibitors in patients with metastatic uveal melanoma and metastatic GNA11/GNAQ mutant melanocytic tumors.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2024.115161

Source records

pubmed · retrieved 2026-09-26T19:04:42.016Z